Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence generation and CDx launch pathways. SEOUL, South Korea and MONTREAL, March 30, 2026...
Hence then, the article about lunit cellcarta announce strategic collaboration to accelerate ai enabled digital pathology for companion diagnostic programs was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs )
Also on site :
- MarketInk: After four decades with Padres and Chargers, Bill Johnston says authenticity & trust are key in any career
- After canceling Iran strikes, Trump says negotiations will resume Monday afternoon while Tehran continues Hormuz talks with Oman
- As AI creates more entrepreneurs and a skills mismatch, Gen Z faces the choice of being a specialist or a ‘general-purpose nerd’